1. Home
  2. CDXS vs ALTI Comparison

CDXS vs ALTI Comparison

Compare CDXS & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • ALTI
  • Stock Information
  • Founded
  • CDXS 2002
  • ALTI 2020
  • Country
  • CDXS United States
  • ALTI United States
  • Employees
  • CDXS N/A
  • ALTI N/A
  • Industry
  • CDXS Major Chemicals
  • ALTI Investment Managers
  • Sector
  • CDXS Industrials
  • ALTI Finance
  • Exchange
  • CDXS Nasdaq
  • ALTI Nasdaq
  • Market Cap
  • CDXS 230.3M
  • ALTI 273.9M
  • IPO Year
  • CDXS 2010
  • ALTI N/A
  • Fundamental
  • Price
  • CDXS $2.81
  • ALTI $3.04
  • Analyst Decision
  • CDXS Buy
  • ALTI
  • Analyst Count
  • CDXS 2
  • ALTI 0
  • Target Price
  • CDXS $11.00
  • ALTI N/A
  • AVG Volume (30 Days)
  • CDXS 1.1M
  • ALTI 148.1K
  • Earning Date
  • CDXS 05-01-2025
  • ALTI 03-13-2025
  • Dividend Yield
  • CDXS N/A
  • ALTI N/A
  • EPS Growth
  • CDXS N/A
  • ALTI N/A
  • EPS
  • CDXS N/A
  • ALTI N/A
  • Revenue
  • CDXS $59,345,000.00
  • ALTI $206,935,000.00
  • Revenue This Year
  • CDXS $14.56
  • ALTI $25.79
  • Revenue Next Year
  • CDXS $21.41
  • ALTI $9.88
  • P/E Ratio
  • CDXS N/A
  • ALTI N/A
  • Revenue Growth
  • CDXS N/A
  • ALTI N/A
  • 52 Week Low
  • CDXS $2.43
  • ALTI $2.33
  • 52 Week High
  • CDXS $6.08
  • ALTI $5.83
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 42.35
  • ALTI 44.53
  • Support Level
  • CDXS $2.43
  • ALTI $2.75
  • Resistance Level
  • CDXS $3.04
  • ALTI $3.07
  • Average True Range (ATR)
  • CDXS 0.22
  • ALTI 0.28
  • MACD
  • CDXS 0.08
  • ALTI 0.03
  • Stochastic Oscillator
  • CDXS 51.35
  • ALTI 63.39

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About ALTI AlTi Global Inc.

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a proven track record with risk adjusted return characteristics.

Share on Social Networks: